Ep 4- Patients Make the Switch

In this episode, Zoe and Conner check in with several patients who’ve made the switch to a biosimilar to find out how they’re doing. Some patients taking a biosimilar have to travel to an infusion site to receive their medication, while others inject their medication at home. In those cases, biosimilars can only be processed and delivered through specialty pharmacies. We hear how several people are handling the adjustment.

"I actually enjoy my infusion day. The best thing to do is call this ‘me time’," says Shelley Fritz, who takes the biosimilar Inflectra for her rheumatoid arthritis and fibromyalgia.

Among the highlights in this episode:

2:00 – Traveling to an infusion site to receive a biosimilar, and what that process entails

4:32 – Self-injecting a biosimilar at home

6:20 – How specialty pharmacies coordinate deliver and follow-up for biosimilars patients

7:19 – Tackling fatigue with a biosimilar

9:17 – How the ‘Spoon Theory’ helps one patient allocate energy resources each day

Contact Our Hosts:

Zoe Rothblatt, Patient Advocate and Community Outreach Manager at GHLF. [e-mail]

Conner Mertens, Patient Advocate and Community Outreach Manager at GHLF. [e-mail]

We’d love to hear what you think. Send your comments to [e-mail]

See omnystudio.com/listener for privacy information.